We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Strong onboarding can go a long way, according to Joe Kramer, vice president of sales, Geri-Care Pharmaceuticals Corp. “Temporary hires bring fresh energy, but they can also create uncertainty, ...

ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) had its price target increased by Guggenheim from $84.00 to $86.00 in a research report sent to investors on Wednesday,Benzinga reports.

But “Anora” isn’t quite so easily boiled down: Thanks to lead actress winner Mikey Madison (Ani) — and many scenes with her co-star, supporting actor nominee Yura Borisov (Igor ...

Ranked by Volume of SBA loan(s) funded or approved in Q4 2024 The key to a thriving business isn’t just hiring the right people—it’s… RALEIGH, NC] — Girl Scouts – North Carolina ...

ANI Pharmaceuticals (ANIP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's ...

DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq ... the potential to rapidly become a standard of care for a rare oncology disease and also contribute ...

The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript February 28, 2025 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.63, expectations were $1.41.

ANI Pharmaceuticals shares rose Friday morning after the company reported better-than-expected results in the fourth quarter and raised its guidance for the current year. Shares traded over 10% ...

ANI Pharmaceuticals (NASDAQ:ANIP) Inc. reported impressive fourth-quarter 2024 earnings, surpassing both earnings per share (EPS) and revenue forecasts, leading to a notable stock price increase. The ...

Generated record quarterly net revenues of $190.6 million, representing year-over-year growth of 44.8%Total Rare Disease quarterly net revenue of ...